Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-118360
Filing Date
2021-09-22
Accepted
2021-09-22 17:00:53
Documents
1
Period of Report
2021-09-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2127534-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2127534-3_4seq1.xml 4 7608
  Complete submission text file 0001104659-21-118360.txt   9006
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Abrahmsen Lars B. (Reporting) CIK: 0001789039 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 211270181